AstraZeneca Clinical Research Collaboration Could Bring AED 180 Million to Abu Dhabi

On 21 October 2026, Abu Dhabi’s Department of Health, Cleveland Clinic Abu Dhabi and AstraZeneca announced a collaboration to explore up to 30 clinical trials by 2030. The initiative could deliver an estimated AED 180 million in life-sciences research investment, with the first six trials expected to begin by the end of 2026; contact HPC for a quotation on research computing, secure data processing and healthcare analytics.